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Several molecules have been identiﬁed as receptors or coreceptors for rotavirus infection, including
glycans, integrins, and hsc70. In this work we report that the tight junction proteins JAM-A, occludin, and
ZO-1 play an important role during rotavirus entry into MA104 cells. JAM-A was found to function as
coreceptor for rotavirus strains RRV, Wa, and UK, but not for rotavirus YM. Reassortant viruses derived
from rotaviruses RRV and YM showed that the virus spike protein VP4 determines the use of JAM-A as
coreceptor.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Rotavirus is an important etiologic agent of gastroenteritis in
children under 3 years of age (Tate et al., 2012). In vivo, this virus
infects primarily mature enterocytes in the intestinal polarized
epithelium, however, most studies on rotavirus biology have been
carried out in nonpolarized cultures of MA104 (epithelial monkey
kidney cells), since these are the cells most permissive for
replication of the virus in cultured cells. Attachment and entry
into the target cell are the ﬁrst steps of viral infection, and several
cell surface molecules have been involved as receptors or core-
ceptors for rotavirus, including sialic acid, integrins, and hsc70
(Lopez and Arias, 2006), and more recently histo-blood group
antigens were also reported to mediate the attachment of some
rotavirus strains (Hu et al., 2012; Huang et al., 2012). In a recent
siRNA screening we obtained evidence that suggested that the
tight junction (TJ) proteins JAM-A, occludin, and ZO-1 might also
play an important role during rotavirus RRV entry into MA104
cells (Silva-Ayala et al., 2013).
JAM-A is an integral TJ protein that possesses two extracellular
V-type Ig domains, one transmembrane domain and a short
carboxy-terminal intracellular domain. JAM-A has been implicated
in the entry of reovirus (Barton et al., 2001) and feline calicivirus
(Makino et al., 2006). Occludin is a tetraspan membrane protein
with two extracellular loops, which are kept apart by a short
intracellular loop. Both, the carboxy- and amino-terminal domains
are cytoplasmic and are involved in several signaling pathways
(Cummins, 2012). Occludin has been involved in the entry of
hepatitis C virus and Coxsackie virus B (Coyne et al., 2007; Ploss
et al., 2009). ZO-1 is a TJ plaque protein that serves as a bridge
between the integral TJ proteins and the actin cytoskeleton, and
acts as an adapter for the intracellular proteins involved in
signaling processes (Chi et al., 2012; Rodgers et al., 2013). So far,
ZO-1 has not been involved in the entry or replication of any virus.
This study addresses the role of JAM-A, occludin, and ZO-1 in the
entry process of various rotavirus strains and identiﬁes the viral
protein that participates in the interaction of the virus with JAM-A.
Results
Tight junction proteins localize to intercellular contacts in conﬂuent
MA104 cell monolayers
Functional TJs are found at the cell–cell contacts in polarized
epithelia or in polarized cell cultures. However, since in this work
we used non-polarized cells, we ﬁrst studied the cellular distribu-
tion of JAM-A, occludin, and ZO-1 in conﬂuent MA104 monolayers.
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JAM-A was detected in nonpermeabilized cells, with most of the
signal showing a typical honeycomb pattern (Fig. 1A), similar to
that observed in polarized cells (Iden et al., 2012). Occludin and
ZO-1 were also readily detected at the intercellular junctions when
the cells were permeabilized, although a large proportion of ZO-1
appeared dispersed in the cytoplasm (Fig. 1B and C).
Different rotavirus strains use tight junction proteins during their
entry into MA104 cells
To characterize the role of JAM-A, occludin, and ZO-1 on the
infectivity of rotavirus strains Wa (human), UK (bovine), YM
(porcine), and RRV (simian), we silenced their expression by RNAi.
When the expression of JAM-A was silenced, the infectivity of
rotavirus strains UK, RRV, and Wa was reduced by about 50%, but
the infectivity of rotavirus YM was not affected (Fig. 2A). Knocking
down the expression of JAM-A did not affect the infectivity of these
viruses when the replication cycle started from transfected DLPs
(Fig. 2A), bypassing the entry step (Silva-Ayala et al., 2013), sugg-
esting that all strains, but YM, use JAM-A to enter MA104 cells.
The knockdown of occludin reduced in 50–60% the infectivity of
all four rotaviruses, and this effect was also exerted at the virus entry
level, as shown by the lack of inhibition when DLPs were transfected
(Fig. 2B). Silencing the expression of ZO-1 also reduced the infectiv-
ity of all strains in 50–70% (Fig. 2C). Since ZO-1 plays an important
role in the formation and maintenance of TJs in polarized cells
(Fanning et al., 1998; Ikenouchi et al., 2007; Umeda et al., 2006), we
determined the cellular localization of JAM-A, and occludin, in ZO-1-
silenced cells. The subcellular localization of both proteins was
altered under these conditions. JAM-A mostly disappeared from
the cell–cell junctions and its overall abundance decreased signiﬁ-
cantly, suggesting a possible degradation of the protein, while the
distribution of occludin shifted, from a mostly junctional localization
to a punctuated cytoplasmic signal (Fig. 2D). These observations
strongly suggest that the localization of both JAM-A and occludin in
nonpolarized MA104 cells is maintained by ZO-1 and that this
localization is necessary for virus entry. This complicates the
evaluation of the effect that silencing ZO-1 might have per se on
the infectivity of the virus. The effect of the various siRNAs used was
speciﬁc for rotaviruses, since the replication of SV40, whose infec-
tivity has not been reported to require TJ proteins, was not affected
by the siRNA treatments (Fig. 2A–C).
Since YM behaves differently from the other rotavirus strains
tested, we evaluated if its phenotype was associated with its
porcine origin. For this, we characterized the effect of silencing
the TJ proteins on the infectivity of the porcine rotavirus strain
Fig. 1. Tight junction proteins localize to intercellular contacts in MA104 cells. MA104 cells on glass coverslips were transfected with the indicated siRNAs using a reverse
method (Silva-Ayala et al., 2013), and 72 hpt cells were ﬁxed and permeabilized (anti-occludin and anti-ZO-1) or not (anti-JAM-A) and stained for indirect
immunoﬂuorescence as indicated under Materials and methods using a monoclonal antibody (MAb J10.4) to the distal membrane extracellular domain of JAM-A, or
polyclonal antibodies to ZO-1, or to the intracellular N-terminal cytoplasmic tail of occludin, as indicated, followed by incubation with secondary Alexa-conjugated
antibodies. siIrre stands for an irrelevant siRNA, which in this immunoﬂuorescence assays was an siRNA against luciferase.
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OSU, which shares the P[7] genotype with rotavirus YM. As can be
seen in Fig. 2A–C, the infectivity of this strain was affected by
silencing the expression of all three TJ proteins, suggesting that
they are important for rotavirus entry independently of the host of
origin and the P genotype, and that the behavior of the porcine
strain YM may be exceptional.
JAM-A functions as coreceptor for rotavirus strains RRV, UK, and Wa
We tested if the monoclonal antibody (MAb) J10.4, directed
against the distal extracellular domain of JAM-A, was capable of
blocking rotavirus infection. The antibody reduced the infectivity of
rotavirus strains RRV, Wa, and UK by about 50%, while it blocked that
of reovirus T3D by 80% (Fig. 3A). This level of inhibition was similar to
that observed for reovirus in Caco-2 cells when the same antibody
was used (Barton et al., 2001). Consistent with our previous observa-
tions, MAb J10.4 did not affect the infectivity of rotavirus YM or SV40.
To determine whether the JAM-A antibody reduced virus infectiv-
ity by blocking the binding of the virus to the cell surface or at a post-
binding step, we added the MAb after the virus had been adsorbed to
the cells. Again, MAb J10.4 reduced the infectivity of rotavirus RRV,
UK, and Wa by approximately 50% when added after the adsorption
period (Fig. 3B), a result that strongly suggests that JAM-A is required
by these viruses at a post-attachment step. In contrast, the infectivity
of reovirus T3D was not affected under these conditions, consistent
with previous reports that indicate that reovirus uses JAM-A for cell
attachment (Kirchner et al., 2008; Zhang et al., 2010).
The requirement of JAM-A for virus entry was conﬁrmed by
testing the ability of soluble puriﬁed JAM-A to block rotavirus
infection when preincubated with the virus before infection. The
puriﬁed protein blocked the infectivity of rotavirus strains RRV,
UK, and Wa, but not YM, by about 60% (Fig. 3C).
To further demonstrate that JAM-A is required at a post-
attachment step, we tested the effect of either preincubating the
cells with the anti-JAM-A antibody J10.4 or preincubating RRV
with soluble JAM-A, on the binding of this rotavirus strain to
MA104 cells. Neither of these treatments blocked the attachment
of the virus to the cell surface (Fig. 3E). Altogether, these results
indicate that JAM-A is able to interact directly with the virus
particle and it is used by rotavirus at a post-binding step.
To test the relevance of JAM-A for rotavirus infection of human
intestinal epithelial cells, we evaluated the ability of the anti-JAM-A
antibody and the soluble form of the protein to block RRV infection of
Caco-2 cells (Fig. 3A and B, hatched bars). Both, MAb J10.4 and the
soluble form of JAM-A, at a concentration of 1 mg/ml, reduced the
infectivity of the virus by about 60%. This result suggests that JAM-A
is a conserved requirement for rotavirus infection of intestinal cells.
Furthermore, we tested if the overexpression of JAM-A in mouse
ﬁbroblasts, which are 100-fold less susceptible than MA104 cells to
rotavirus infection (Bass et al., 1992) would increase their suscept-
ibility for virus replication. Fig. 3D shows that overexpression of a
full length JAM-A protein increased the infectivity of RRV by about
50%, while a JAM-A molecule with a truncated carboxy-terminal did
not facilitate rotavirus infection. These observations suggest that the
presence of JAM-A renders L cells more susceptible for rotavirus RRV
infection and that the cytoplasmic tail of the protein may play a role
in virus entry, probably by triggering a signaling cascade. On the
other hand, overexpression of the CAR receptor, a protein related to
JAM-A (Bergelson et al., 1997; Luissint et al., 2014), did not support
the increase in infectivity of rotavirus RRV, showing the speciﬁc use
of JAM-A by the virus.
The spike protein VP4 deﬁnes the requirement of rotavirus strain RRV
for JAM-A during cell entry
We have reported that VP4 deﬁnes the endocytic pathway and
the intracellular vesicular trafﬁc used by rotaviruses in MA104
cells (Diaz-Salinas et al., 2013, 2014). Here, to determine which viral
Fig. 2. Different rotavirus strains use TJ proteins during their entry into MA104 cells. MA104 cells were transfected with siRNAs against (A) JAM-A, (B) ZO-1 or (C) Occludin,
using a reverse method. After 72 hpt, cells were infected with rotavirus strains RRV, UK, Wa, and YM (open bars) or OSU (hatched bar) at a MOI of 0.02, or with SV40 (gray
bars). Cells lipofected with puriﬁed DLPs of the indicated strains at a concentration that would infect cells at an MOI equivalent to 0.02 are also shown (closed bars). At 14 hpi
the cells were ﬁxed and immunostained for a peroxidase assay as described in Materials and methods. Data were normalized against the infectivity of each virus in cells
treated with an siRNA against luciferase. (D) MA104 cells were transfected with an siRNA against ZO-1 and 72 hpt the cells were ﬁxed and prepared for an
immunoﬂuorescence assay as described in Materials and methods, using MAb J10.4, directed to JAM-A, or a polyclonal antibody to occludin. Secondary antibodies coupled
with Alexa were used for signal detection. The arithmetic means7standard deviation of three independent experiments is shown. nnn, Po0.001.
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protein was responsible for the interaction with JAM-A, we took
advantage of the differential dependence of RRV and YM on JAM-A,
and the availability of a panel of RRVYM reassortant viruses
(Espinoza et al., unpublished results, Fig. 4A). The infectivity of the
parental strains and the reassortant viruses was tested on cells
treated with an siRNA directed to JAM-A. We found that the reass-
ortants having the VP4 of YM showed the same phenotype as the
parental YM strain (Fig. 4B). These included reassortants that had
either the VP4 and VP7 proteins of YM (13-7) or only the VP4 protein
of YM (13-4) in a background of RRV structural proteins. On the other
hand, the infectivity of reassortant 34-4, which has the VP7 gene of
RRV in the genetic background of YM was not affected. A reassortant
having the VP4 protein of RRV in a YM background was not available,
nevertheless, an RRV reassortant having only the VP3 protein of YM
(10-3) behaved as the parental RRV. These results suggest that VP4,
but not VP7, deﬁnes the requirement of JAM-A for rotavirus infection.
Similar results were obtained when MAb J10.4 was used to block the
infection of the RRVYM reassortants (Fig. 4C).
Discussion
Diverse viruses use proteins of the apical junctional complex
(tight and adherence junctions) as receptors or coreceptors for cell
infection (Barton et al., 2001; Benedicto et al., 2012; Gonzalez-
Mariscal et al., 2009). In this work we identiﬁed JAM-A as a
coreceptor for the entry of some rotavirus strains into nonpolarized
MA104 cells, and also showed that occludin and ZO-1 are required
during the entry process. We have previously reported that RRV
internalizes into cells by clathrin-independent endocytosis, while
rotaviruses YM, Wa, and UK enter cells by a clathrin-dependent
endocytic pathway (Diaz-Salinas et al., 2013; Gutierrez et al., 2010).
These observations suggest that the use of JAM-A does not deﬁne
the endocytic pathway followed by the virus but that it is more
likely involved in an entry step yet to be deﬁned. It has been shown
for reovirus that JAM-A is dispensable for replication in intestinal
and neural cells in mice, but it is required for systemic dissemination
in the organism (Boehme et al., 2013). It remains to be investigated
whether rotavirus uses JAM-A for a similar purpose in those cases
where the extraintestinal spread of the virus has been observed
(Blutt and Conner, 2007), and whether the TJ function itself is
important for rotavirus cell entry in polarized epithelia. The role of
occludin and ZO-1 on rotavirus entry needs to be further character-
ized, but these proteins may serve as scaffold to recruit and anchor
signaling or regulatory molecules in the vicinity of virus entry, as
suggested for occludin in the case of Coxsackie B virus (Coyne et al.,
2007). Of interest, infection with rotavirus RRV was previously
reported to alter the distribution of occludin in polarized Caco-2
cells by a protein A-dependent mechanism, although this change in
distribution was not associated with an impaired virus replication
(Beau et al., 2007).
Even though several molecules have been described as rotavirus
receptors (Lopez and Arias, 2006), this is the ﬁrst time that a set of
proteins that belong to a structural feature of polarized epithelia has
been associated with rotavirus entry. These ﬁndings, together with
the previous involvement of glycans as virus receptors (Hu et al.,
2012; Isa et al., 2006; Martinez et al., 2013), and integrins (a2b1 and
avb3) and hsc70 as coreceptors (Lopez and Arias, 2006), provide
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Fig. 3. JAM-A is a coreceptor for rotavirus. MA104 cells were incubated with either an antibody against JAM-A (MAb J10.4) or a control IgG isotype (CD47) for 1 h at 41C
before (A) or after (B) attachment of the indicated virus for 1 h at 4 1C as indicated in Materials and methods. Cells were shifted to 37 1C and the infection was allowed to
proceed for 14 h. Virus infectivity was measured using an immunoperoxidase focus forming unit (FFU) assay. Data were normalized against the infectivity of each virus in
mock treated cells. The hatched bar shows the infectivity of RRV in Caco-2 cells. (C) Puriﬁed JAM-A protein at a concentration of 1 mg/ml was incubated for 1 h at 4 1C with
the indicated virus; JAM-A pre-treated virus was then incubated with MA104 cells and 14 hpi cells were ﬁxed and immunostained as described inMaterial and methods. Data
were normalized against the infectivity of each virus in mock-treated cells. The hatched bar shows the infectivity of RRV in Caco-2 cells. (D) L929 mouse ﬁbroblasts were
transfected with plasmids encoding a wild-type or a mutant version (ΔCT) of JAM-A, or wild-type CAR and, at 48 hpt, infected with 2000 FFUs per well of rotavirus strain
RRV. Virus infectivity in cells expressing the indicated proteins was obtained normalizing against the infectivity observed in nontransfected cells. The arithmetic
means7standard deviation of three independent experiments is shown. nn, Po0.01; nnn, Po0.001. (E) MA104 cells were incubated with MAb J10.4 for 1 h at 4 1C, and then
further incubated with 500 ng of CsCl-puriﬁed RRV TLPs for 1 h at 4 1C (J10.4), or with 500 ng of puriﬁed RRV TLPs that were previously treated with 1 mg/ml of soluble JAM-
A (JAM-A). After this time the unbound virus was washed away with cold PBS and the bound virus was determined by ELISA as described in Material and methods.
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a complex panorama for the cell entry of this large nonenveloped
virus. Despite the ample catalog of cellular molecules that have
been involved in virus entry, one wonders if the list is complete and
whether all described receptors/coreceptors function in concert as a
very complex entry machinery or provide alternative routes of
infection that might be relevant during replication of the virus in
a natural host.
Materials and methods
Cells and viruses
The rhesus monkey epithelial cell line MA104 and the murine
ﬁbroblasts cell line L929 (ATCC) were grown in advanced Eagle's
minimal essential medium (MEM) (Invitrogen) supplemented with
5% and 10% fetal bovine serum (FBS), respectively, at 37 1C in a 5%
CO2 atmosphere. Human intestinal epithelial cells (Caco-2, clone
C2Bb1) were grown in high glucose DMEM supplemented with 10%
FBS and nonessential amino acids. Rhesus rotavirus RRV and bovine
rotavirus UK were kindly donated by Y. Hoshino (NIAID-NIH,
Bethesda, MD), and have been previously described (Diaz-Salinas
et al., 2013; Feng et al., 2009). Rotavirus human strain Wa was
obtained from H. B. Greenberg (Stanford University, Stanford CA),
and the porcine rotavirus OSU from L. Saif (Ohio State University,
Wooster, OH). The porcine rotavirus strain YM was isolated in our
laboratory (Ruiz et al., 1988). The YMRRV rotavirus reassortants
were generated in our laboratory. All rotavirus strains were propa-
gated in MA104 cells as previously described (Pando et al., 2002).
Rotavirus cell lysates were activated with trypsin (10 mg/ml) for
30 min at 37 1C. Triple-layered particles (TLPs) and double-layered
particles (DLPs) of RRV, UK, Wa, and YM strains were puriﬁed by
CsCl isopycnic gradients as described (Pando et al., 2002). The
mammalian reovirus strain type 3 Dearing (ReoT3D) was a kind
donation of T. S. Dermody (Vanderbilt University, Nashville TN).
ReoT3D was propagated in L929 cells and the viral titer was
determined in MA104 cells as previously described (Cuadras et al.,
1997; Gutierrez et al., 2010). Simian virus 40 (SV40) was obtained
from L. Gutiérrez (National Institute of Public Health, Cuernavaca,
Mexico). SV40-infected cells were detected by a ﬂuorescence focus
assay using an anti-SV40 TAg MAb as described previously (Stang
et al., 1997).
Antibodies, reagents, and plasmids
Monoclonal antibody (MAb) J10.4 against the extracellular
membrane-distal domain of JAM-A was purchased from Santa Cruz
Biotechnology (Dallas, TX). MAb CD47 was from Abcam, (Cam-
bridge, UK). Polyclonal antibodies to ZO-1 and the intracellular
C-terminal cytoplasmic tail of occludin were purchased from Life
Technologies (Grand Island, NY). 40,60-diamidino-2-phenylindole
(DAPI), Alexa 488- and 568-conjugated secondary antibodies were
from Molecular Probes (Grand Island, NY). Rabbit hyperimmune
sera to puriﬁed RRV rotavirus particles (α-TLPs), and to puriﬁed
reovirus particles (α-Reo) were produced in our laboratory. Horse-
radish peroxidase-conjugated goat anti-rabbit polyclonal antibody
was from Perkin Elmer Life Sciences (Waltham, MA). Afﬁnity
puriﬁed JAM-A was obtained from Sino Biological Inc. (Beijing,
China). Paraformaldehyde, bovine serum albumin (BSA), and Triton
X-100 were purchased from Sigma-Aldrich Co. (St. Louis, MO). The
siRNAs were obtained from Dharmacon-Thermo Scientiﬁc (Pitts-
burg, PA). pcDNA3.1 encoding human JAM-A, JAM-A ΔCT, and
human CAR were kindly provided by T. S. Dermody (Vanderbilt
University, Tennessee).
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Fig. 4. The VP4 protein deﬁnes the use of JAM-A as coreceptor. (A) Origin of the capsid proteins of the YMxRRV reassortants used in this study. (B) MA104 cells were
transfected with an siRNA against JAM-A and infected with the indicated virus (2000 FFUs). At 14 hpi the cells were ﬁxed and immunostained for a peroxidase assay. Data
were normalized against the infectivity of each virus in cells treated with an irrelevant siRNA. (C) MA104 cells were incubated with MAb J10.4, directed to JAM-A, for 1 h at
4 1C after the indicated virus had been attached to cells for 1 h at 4 1C, as indicated in Materials and methods. At 14 hpi the cells were ﬁxed and immunostained for a
peroxidase assay. Data were normalized against the infectivity of each virus in cells incubated with a control IgG isotype (CD47). Closed bars, RRV and reassortants bearing
RRV VP4; open bars, YM and reassortants bearing YM VP4. The arithmetic means7standard deviation of three independent experiments is shown. nnn, Po0.001.
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Immunoﬂuorescence
MA104 cells were grown to conﬂuence on glass coverslips and
then ﬁxed with 2% formaldehyde in PBS for 20 min at room temp-
erature. After this time, cells were washed three times with PBS
containing 50 mM NH4Cl, and then permeabilized or not by incuba-
tion with 0.5% Triton X-100 in blocking buffer [50 mM NH4Cl, 1% BSA
in PBS] for 15 min, washed three times with PBS containing 50 mM
NH4Cl, and blocked by incubation overnight at 4 1C with 1% BSA and
50 mM NH4Cl in PBS. The coverslips were incubated with primary
antibodies for 1 h, followed by incubation with the corresponding
Alexa-labeled secondary antibodies for 1 h. All incubations were
performed at room temperature. Coverslips were mounted on glass
slides using Fluokeep (Argene, Varilhes, France) and were analyzed
with a ﬂuorescence microscope (Zeiss Axioskop 2 mot plus) coupled
to a digital camera (Photometrics Cool Snap HQ). The images were
then digitally captured and prepared in Adobe Photoshop 6.0.
Transfection of siRNAs
The indicated siRNAs were transfected into MA104 cell by a
reverse method as described (Lopez et al., 2012). As control, an
siRNA against luciferase was used. At 24 h post-transfection (hpt)
the transfection mixture was removed and fresh Advanced DMEM-
5% SFB was added; 72 hpt the cells were washed twice with MEM
and subsequently infected with the indicated rotavirus strains.
None of the assayed siRNAs was toxic for the cells, as determined
by a lactate dehydrogenase (LDH) release assay, using a commer-
cial kit (Sigma-Aldrich Co.; St. Louis, MO).
Infectivity assay
Conﬂuent MA104 cells in 96-well plates (for rotavirus and reovirus
infection) or 24-well plates (for SV40 infection) were washed twice
with MEM, and then approximately 2000 focus-forming units (FFU) of
rotavirus or reovirus, or 6000 FFU of SV40 were adsorbed per well of
cells during 60min at 37 1C. After the adsorption period, the virus
inoculumwas removed, MEMwas added, and the infectionwas left to
proceed at 37 1C for 16 h for reovirus and rotavirus strains, or 18 h for
SV40. Infected cells were detected by an immunoperoxidase focus-
forming units assay using anti-TLPs for RRV, UK, OSU, and YM, a
hyperimmune serum to rotavirus Wa, or α-Reo for reovirus, as
described previously (Gutierrez et al., 2010). Brieﬂy, cell monolayers
were ﬁxed with 80% acetone in PBS, and intracellular viral antigenwas
detected with primary polyclonal antibodies followed by a peroxidase-
conjugated goat anti-rabbit polyclonal antibody as described. The FFUs
were counted in a Visiolab 1000 station (Biocom, Les Ulises, France) as
reported previously (Guerrero et al., 2000). SV40-infected cells were
detected by a ﬂuorescence focus assay using an anti-SV40 TAg MAb as
described previously (Stang et al., 1997).
Blocking assays
For the antibody blocking assays, MA104 cells were grown to
conﬂuence on 96-well plates and then incubated for 1 h at 4 1C with
either 1 μg/ml of anti JAM-A MAb J10.4 or 20 μg/ml of an antibody
against CD47 as an isotype control. Cells were then infected with
2000 FFUs per well of the corresponding rotavirus strains and the
infected cells were detected using the immunoperoxidase assay
described above. To determine if the antibody had an effect on
binding of the virus or in a post-binding step, MA104 cells were
grown to conﬂuence in 96-well plates and then incubated for 1 h at
4 1C with 2000 FFUs per well of the corresponding rotavirus strains.
After virus attachment, the unbound virus was removed by washing
the cells twice with cold MEM and then either 1 μg/ml of Mab J10.4
or 20 μg/ml of antibody against CD47 were added for 1 h at 4 1C.
After this incubation period the cells were washed twice with cold
MEM to remove the unbound antibody and then were shifted to
37 1C and the infection was allowed to proceed for 14 h. Rotavirus-
infected cells were detected by the immunoperoxidase assay des-
cribed above. To test the ability of puriﬁed JAM-A to block rotavirus
infection the puriﬁed protein at a concentration of 1 μg/ml was
incubated for 1 h at 4 1C with 2000 FFUs of the corresponding
rotavirus strains. MA104 cells were then incubated for 1 h with the
JAM-A pre-treated virus. After this incubation period, the unbound
virus was removed by washing the cells twice with cold MEM and
the infection was allowed to proceed for 14 h and the infected cells
were detected as described above.
Binding assay
MA104 cells were incubated with 1 μg/ml of MAb J10.4 for 1 h
at 4 1C followed by addition of 500 ng of Cs-Cl puriﬁed RRV
particles for 1 h at 4 1CC. Alternatively, the cells were incubated
with MEM for 1 h at 4 1C, and then 500 ng of puriﬁed RRV viral
particles that had been previously incubated with 1 μg/ml of
soluble JAM-A was added for 1 h at 37 1C. After the incubation
period the unbound virus was removed by washing the cells with
cold PBS and then the cells were lysed with 125 μl of lysis buffer
(50 mM Tris [pH 7.5], 150 mM NaCl, 0.1% Triton X-100) The
percentage of bound virus was calculated by an ELISA as pre-
viously described (Zárate et al., 2000).
Rotavirus infection in cells overexpressing JAM-A
L929 cells were grown on glass coverslips to 70% conﬂuence and
were then transfected with 500 ng of a plasmid encoding hJAM-A
(pcDNA3.1/JAM-A), hCAR (pcDNA3.1/CAR) or with the empty
pcDNA3.1 vector (Barton et al., 2001) using lipofectaminesLTX (Life
Technologies). At 48 hpt, the transfected cells were infected with
2000 FFUs per well of rotavirus strain RRV, and the infected cells
were detected by an immunoperoxidase assay, as described in
Materials and methods. The transfection efﬁciency was about 40%
as determined by immunoﬂuorescence using MAb J10.4.
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